Biology Derived Solutions – BDS
Peptides are powerful therapeutics, owing to their specificity, safety and tolerability. BDS has developed in the lab a proprietary peptide, BDS-1, derived from an endogenous protein and able to halt neuroblastoma growth in vitro and in vivo and without triggering toxicity in healthy cells. BDS technologies can lead to the development of new drug therapies for curing cancer.
Subscribe to our newsletter to receive
our news right in your inbox!